Laboratory of Tissue Repair and Regeneration, Matrix Dynamics Group, Faculty of Dentistry, Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, Canada.
Laboratory of Tissue Repair and Regeneration, Matrix Dynamics Group, Faculty of Dentistry, Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, Canada.
Matrix Biol. 2018 Aug;68-69:81-93. doi: 10.1016/j.matbio.2018.01.019. Epub 2018 Jan 31.
Scarring is part of the normal healing response to tissue injury in all organs and required to rapidly repair acute damages, mostly with extracellular matrix. A variety of different cells are activated into myofibroblasts to produce and remodel the scar matrix. Temporal and spatial coordination of myofibroblast activities with inflammatory macrophages is crucial for the controlled healing process. Miscommunication can result in either insufficient (chronic) or exacerbated (fibrotic) repair. In addition to soluble biochemical signals and intercellular contacts, cell-to-cell communication is mediated by biophysical and chemical signals transmitted through the extracellular matrix. Over the course of healing, the matrix takes over the role of a master coordinator; failure to do so produces poor healing outcomes that reduce organ function. Understanding the mechanical and chemical state of the matrix and its effects on cellular processes will be essential to address diseases that are characterized by dysfunctional matrix, such as fibrosis.
瘢痕形成是所有器官组织损伤后正常愈合反应的一部分,需要迅速修复急性损伤,主要通过细胞外基质来完成。多种不同的细胞被激活为肌成纤维细胞,以产生和重塑瘢痕基质。肌成纤维细胞的活动与炎症巨噬细胞的时空协调对于控制愈合过程至关重要。如果沟通不畅,可能会导致修复不足(慢性)或过度(纤维化)。除了可溶性生化信号和细胞间接触外,细胞间通讯还通过通过细胞外基质传递的生物物理和化学信号进行介导。在愈合过程中,基质承担了主协调器的角色;如果不能完成这一角色,就会导致愈合不良,从而降低器官功能。了解基质的力学和化学状态及其对细胞过程的影响,对于解决以基质功能障碍为特征的疾病(如纤维化)至关重要。
Curr Res Transl Med. 2016-11-4
Cold Spring Harb Perspect Biol. 2023-1-3
Exp Eye Res. 2016-1
Annu Rev Pathol. 2012-10-22
Methods Mol Biol. 2021
J Mol Cell Cardiol. 2016-4
Stem Cell Res Ther. 2025-8-20
Cell Death Discov. 2025-7-15
Life (Basel). 2025-6-11
Nat Rev Nephrol. 2025-6-19
FASEB Bioadv. 2025-4-3